E
ENDRA Life Sciences Inc. NDRA
$4.09 -$0.0519-1.25% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1.23M -1.04M -4.15M -2.35M -2.23M
Total Depreciation and Amortization 32.80K 45.60K 46.40K 54.00K 50.10K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 26.70K -325.50K 2.38M 873.80K 48.50K
Change in Net Operating Assets 52.80K 23.10K 211.10K -230.90K 47.20K
Cash from Operations -1.11M -1.29M -1.52M -1.66M -2.08M
Capital Expenditure 0.00 -17.30K 0.00 0.00 11.00K
Sale of Property, Plant, and Equipment -- -- 0.00 0.00 0.00
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 0.00 -17.30K 0.00 0.00 11.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 0.00 0.00 0.00
Issuance of Common Stock 857.40K 145.80K 0.00 -- 7.34M
Repurchase of Common Stock -- -- -- -6.69M --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 6.69M --
Cash from Financing 857.40K 145.80K 0.00 1.70K 7.34M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- 0.00 0.00 --
Net Change in Cash -256.30K -1.16M -1.52M -1.66M 5.27M